SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of BioClinica, Inc. Shareholders

[January 30, 2013]

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of BioClinica, Inc. Shareholders

NEW YORK --(Business Wire)--

Kirby McInerney LLP is investigating potential claims against the Board of Directors of BioClinica, Inc. ("BioClinica" or the "Company") (NASDAQ: BIOC) related to the proposed acquisition of the Company by JLL Partners, Inc., a private equity firm. Under the terms of the agreement, JLL Partners will commence a cash tender offer to purchase all of BioClinica's common stock for $7.25 per share, valuing the Company at approximately $123 million.

The investigation concerns whether the BioClinica Board of Directors violated its fiduciary duties by agreeing to this transaction and whether the proposed $7.25 per share consideration adequatelyvalues BioClinica shares. The offer price represents a 19% premium to the closing price of BioClinica shares the day prior to the announcement. At least one analyst has a price target for the Company's stock of $9.00 per share, 24% above the offer price.


If you are a BioClinica shareholder and wish to obtain additional information, please contact J. Brandon Walker, Esq. by email at bwalker@kmllp.com, or by telephone at (212) 699-1145 or (888) 529-4787, or by filling out this contact form.

Kirby McInerney LLP is a New York-based law firm concentrating in securities, shareholder, whistleblower, antitrust and consumer litigation. For additional information, please go to www.kmllp.com.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.